TrialSignal
Clinical trial intelligence report
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC)
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 24, 2026
Report code
NCT02027571-Jun 24, 2026
NCT ID
NCT02027571
Status
COMPLETED
Phase
Completed
Sponsor
University of Tennessee
Executive brief
Investment-Ready Snapshot
The PROP-ABC study, sponsored by the University of Tennessee, investigates the pathobiology and reversibility of prediabetes in a biracial cohort, specifically targeting individuals with a familial history of type 2 diabetes. With nearly 400 participants, the study aims to elucidate the factors contributing to prediabetes and assess the effectiveness of intensive lifestyle interventions (ILI). Given the rising prevalence of diabetes and prediabetes, this research could inform future therapeutic strategies and public health initiatives. The findings may enhance the competitive positioning of lifestyle intervention programs in diabetes prevention and management, particularly in racially diverse populations. The study's completion and subsequent data analysis may attract interest from pharmaceutical companies and health organizations focused on diabetes prevention.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02027571
Indication
Prediabetes
Modality
behavioral intervention
Target
Not specified; focuses on lifestyle intervention for reversing prediabetes.
Intervention
Intensive Lifestyle Intervention (ILI)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.